Back
Harte-Hanks Vs. Novo Nordisk AS Industry Stock Comparison
Sell
31
HHS
Harte-Hanks
Last Price:
$5.23
Seasonality Move:
3.49%
Sell
9
NONOF
Novo Nordisk AS
Last Price:
$85.04
Seasonality Move:
8.64%
Sell
31
Harte-Hanks (HHS)
is a Sell
Is Harte-Hanks a Buy, Sell or Hold?
-
The current Harte-Hanks [HHS] share price is $5.16. The Score for HHS is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
HHS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
9
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $83.49. The Score for NONOF is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
HHS Stock Price Chart
What is Harte-Hanks's stock price today?
-
The Harte-Hanks share price today is $5.16Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HHS is experiencing slight selling pressure.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $83.49Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
HHS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 35.53 | Sell |
Chaikin Money Flow: | -12271 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.25 - 5.77) | Sell |
Bollinger Bands (100): | (5.88 - 7.58) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.33 | Sell |
Relative Strength Index (14 RSI): | 28.84 | Sell |
Chaikin Money Flow: | -3979 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (87.37 - 110.31) | Sell |
Bollinger Bands (100): | (100 - 129.72) | Sell |
HHS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.26 | Sell |
20-day SMA: | 5.47 | Sell |
50-day SMA: | 6.07 | Sell |
200-day SMA: | 7.17 | Sell |
8-day EMA: | 5.27 | Sell |
20-day EMA: | 5.45 | Sell |
50-day EMA: | 5.96 | Sell |
200-day EMA: | 6.9 | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.05 | Sell |
20-day SMA: | 96.21 | Sell |
50-day SMA: | 103.01 | Sell |
200-day SMA: | 123.85 | Sell |
8-day EMA: | 86.84 | Sell |
20-day EMA: | 93.21 | Sell |
50-day EMA: | 102.18 | Sell |
200-day EMA: | 114.99 | Sell |
Harte-Hanks Earnings Growth & HHS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.50 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Harte-Hanks Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |